Pharmalot... Pharmalittle... Good Morning

Rise and shine, everyone, another busy day is on the way. As usual, the Pharmalot corporate campus is humming this morning as the short people bounce out the door to their schoolhouses and the official mascots chase wildlife around the grounds. As for us, we are preparing for another round of meetings and phone calls and research. We trust you relate, so please join us for the mandatory cup of stimulation. Although we are trying something a wee bit different today - a spot of Earl Grey tea, with milk. Whatever you fancy, hope you have a wonderful day and conquer the world...
Glaxo Shifts Some Retirees To Health Exchanges (Philadephia Inquirer)
AstraZeneca Lab Closing Threatends 71 Jobs In The UK (BBC News)
McKesson Agrees To Buy Celesio For $5.4 Billion (Bloomberg News)
Indian Regulators Slow Clinical Trial Approvals (Business Standard)
FDA Questions Credibility Of Repros Testosterone Pill Data (The Street)
FDA Reviewers Back Gilead Hepatitis C Drug Sofosbuvir (BioCentury)
FDA Designates Merck Hep C Combo As A Breakthrough (Pharma Times)
...Read more

Source: Pharmalot - October 24, 2013 Category: Pharma Commentators Authors: esilverman Source Type: blogs